202 related articles for article (PubMed ID: 20018549)
1. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.
Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS
Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549
[TBL] [Abstract][Full Text] [Related]
2. The relationship between impulsivity and impulse control disorders in Parkinson's disease.
Isaias IU; Siri C; Cilia R; De Gaspari D; Pezzoli G; Antonini A
Mov Disord; 2008 Feb; 23(3):411-5. PubMed ID: 18067187
[TBL] [Abstract][Full Text] [Related]
3. Impulse control disorders and punding in Parkinson's disease: the need for a structured interview.
Ávila A; Cardona X; Bello J; Maho P; Sastre F; Martín-Baranera M
Neurologia; 2011 Apr; 26(3):166-72. PubMed ID: 21163239
[TBL] [Abstract][Full Text] [Related]
4. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
5. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.
O'Sullivan SS; Djamshidian A; Ahmed Z; Evans AH; Lawrence AD; Holton JL; Revesz T; Lees AJ
Mov Disord; 2010 Apr; 25(5):638-42. PubMed ID: 20213825
[TBL] [Abstract][Full Text] [Related]
6. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
[TBL] [Abstract][Full Text] [Related]
8. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
9. Compulsive behaviors in patients with Parkinson's disease.
Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
[TBL] [Abstract][Full Text] [Related]
10. Compulsive eating and weight gain related to dopamine agonist use.
Nirenberg MJ; Waters C
Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
[TBL] [Abstract][Full Text] [Related]
11. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
Weintraub D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic dysregulation syndrome in Parkinson's disease.
Katzenschlager R
J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
[TBL] [Abstract][Full Text] [Related]
14. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
[TBL] [Abstract][Full Text] [Related]
15. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.
Potenza MN; Voon V; Weintraub D
Nat Clin Pract Neurol; 2007 Dec; 3(12):664-72. PubMed ID: 18046439
[TBL] [Abstract][Full Text] [Related]
16. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
17. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
[TBL] [Abstract][Full Text] [Related]
18. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
19. Medication-related impulse control and repetitive behaviors in Parkinson disease.
Voon V; Fox SH
Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
